Your Yourlocation: Home > Observation of tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease during stable period

To investigate the clinical effect of tiotropium bromide(136310-93-5) in the treatment of stable patients with chronic obstructive pulmonary disease (COPD).

Methods: Sixty patients with stable COPD were randomly divided into two groups. The control group was treated with conventional therapy. The treatment group was treated with tiotropium 18μg /d inhalation on the control group. Three months before treatment and 3 months after treatment Months of lung function, dyspnea index, 6rain walking test and other indicators.

Results: After 6 months and 6 months, the lung function index, 6 min walking distance and quality of life score of the treatment group were significantly improved (P <0.05), and there was significant difference compared with the control group <0.05).

Conclusion: Tiotropium bromide(136310-93-5) can not only improve the endurance of COPD patients, but also can improve the quality of life of patients.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved